Abstracts tagged "juvenile sclerosis and systemic sclerosis"

Abstract Number: 2389 • 2016 ACR/ARHP Annual Meeting
Is There a Difference in the Presentation of Diffuse and Limited Subtype in Childhood? Results from the Juvenile Scleroderma Inception Cohort
Ivan Foeldvari¹, Jens Klotsche², Ozgur Kasapcopur³, Amra Adrovic⁴, Valda Stanevicha⁵, Maria Teresa Terreri⁶, Ekaterina Alexeeva⁷, Maria M. Katsicas⁸, Rolando Cimaz⁹, Mikhail Kostik¹⁰, Thomas J. A. Lehman¹¹, Walter A. Sifuentes-Giraldo¹², Vanessa Smith¹³, Flavio Sztajnbok¹⁴, Tadey Avcin¹⁵, Maria Jose Santos¹⁶, Dana Nemkova¹⁷, Cristina Battagliotti¹⁸, Despina Eleftheriou¹⁹, Liora Harel²⁰, Mahesh Janarthanan²¹, Tilmann Kallinich²², Jordi Anton²³, Kirsten Minden², Susan Mary Nielsen²⁴, Kathryn S. Torok²⁵, Yosef Uziel²⁶ and Nicola Helmus¹, ¹Hamburg Center for Pediatric and Adolescent Rheumatology, Hamburg, Germany, ²Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ³Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ⁴Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, ⁵University Childrens Hospital, Riga, Latvia, ⁶Pediatric Rheumatology Unit, Federal University of São Paulo, São Paulo, Brazil, ⁷Scientific Centre of Children’s Health of RAMS, Moscow, Russia, ⁸Service of Immunology & Rheumatology. Hospital de Pediatrìa Prof Dr.Juan.P. Garrahan, MD, Buenos Aires, Argentina, ⁹Pediatric Rheumatology, Anna Meyer Children's Hospital, Florence, Italy, ¹⁰Hospital Pediatrics, State Pediatric Medical University, Saint-Petersburg, Russia, ¹¹Chief Div Ped Rheum PTD, Hospital for Special Surgery, New York, NY, ¹²Department of Rheumatology, University Hospital Ramón y Cajal, Madrid, Spain, ¹³Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, ¹⁴Pediatric Rheumatology Division, Adolescent Health Care Unit, Universida de do Estado do Rio de Janeiro., Rio de Janeiro, Brazil, ¹⁵University Children's Hospital, Ljubljana, Slovenia, ¹⁶Rheumatology, Department of Rheumatology, Hospital Garcia de Orta, Almada, Portugal, Almada, Portugal, ¹⁷Pediatric Rheumatology Unit, Department of Pediatrics and Adolescent Medicine, General University Hospital in Prague, Prague, Czech Republic, ¹⁸Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ¹⁹Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ²⁰Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel, ²¹Pediatric Rheumatology, Chennai, India, ²²Charite, University Medicine Berlin, Berlin, Germany, ²³Unitat de Reumatologia Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain, ²⁴Rigshospitalet, Copenhagen, Denmark, ²⁵Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ²⁶Meir Medical Center, Kfar Saba, Israel
Background/Purpose: Juvenile systemic sclerosis (jSSc) is an orphan autoimmune disease. Several adult publications looked at the differences between limited (ljSSc) and diffuse subtype (djSSc). There…
Abstract Number: 2391 • 2016 ACR/ARHP Annual Meeting
Update on the Juvenile Systemic Sclerosis Inception Cohort Project. Characteristics of the First 80 Patients at First Assessment
Ivan Foeldvari¹, Jens Klotsche², Ozgur Kasapcopur³, Amra Adrovic⁴, Valda Stanevicha⁵, Ana Paula Sakamoto⁶, Ekaterina Alexeeva⁷, Maria M. Katsicas⁸, Rolando Cimaz⁹, Mikhail Kostik¹⁰, Thomas J. A. Lehman¹¹, Walter A. Sifuentes-Giraldo¹², Vanessa Smith¹³, Flavio Sztajnbok¹⁴, Tadey Avcin¹⁵, Maria Jose Santos¹⁶, Dana Nemkova¹⁷, Cristina Battagliotti¹⁸, Despina Eleftheriou¹⁹, Liora Harel²⁰, Mahesh Janarthanan²¹, Tilmann Kallinich²², Jordi Anton²³, Kirsten Minden², Susan Mary Nielsen²⁴, Kathryn S. Torok²⁵, Yosef Uziel²⁶ and Nicola Helmus²⁷, ¹Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, ²Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ³Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ⁴Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, ⁵University Childrens Hospital, Riga, Latvia, ⁶Pediatric Rheumatology Unit, Federal University of São Paulo, São Paulo, Brazil, ⁷Rheumatology, Scientific Center of Children's Health, Moscow, Russia, ⁸Service of Immunology & Rheumatology. Hospital de Pediatrìa Prof Dr.Juan.P. Garrahan, MD, Buenos Aires, Argentina, ⁹Pediatrics, University of Firenze, Firenze, Italy, ¹⁰Hospital Pediatrics, State Pediatric Medical University, Saint-Petersburg, Russia, ¹¹Chief Div Ped Rheum PTD, Hospital for Special Surgery, New York, NY, ¹²Department of Rheumatology, University Hospital Ramón y Cajal, Madrid, Spain, ¹³Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, ¹⁴Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ¹⁵University Children's Hospital, Ljubljana, Slovenia, ¹⁶Rheumatology, Department of Rheumatology, Hospital Garcia de Orta, Almada, Portugal, Almada, Portugal, ¹⁷Pediatric Rheumatology Unit, Department of Pediatrics and Adolescent Medicine, General University Hospital in Prague, Prague, Czech Republic, ¹⁸Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ¹⁹Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ²⁰Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel, ²¹Pediatric Rheumatology, Chennai, India, ²²Charite, University Medicine Berlin, Berlin, Germany, ²³Unitat de Reumatologia Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain, ²⁴Rigshospitalet, Copenhagen, Denmark, ²⁵Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ²⁶Meir Medical Center, Kfar Saba, Israel, ²⁷Hamburg Center for Pediatric and Adolescent Rheumatology, Hamburg, Germany
Background/Purpose: Juvenile systemic sclerosis (jSSc) is an orphan autoimmune disease. Currently just retrospective data exist regarding evolvement of organ involvement. In the retrospective studies assessment…
Abstract Number: 2393 • 2016 ACR/ARHP Annual Meeting
Medication Use in the Juvenile Systemic Sclerosis Inception Cohort. ARE There Differences in the Diffuse and Limited Subset Patients?
Ivan Foeldvari¹, Jens Klotsche², Ozgur Kasapcopur³, Amra Adrovic⁴, Valda Stanevicha⁵, Maria Teresa Terreri⁶, Ekaterina Alexeeva⁷, Maria M. Katsicas⁸, Rolando Cimaz⁹, Mikhail Kostik¹⁰, Thomas J. A. Lehman¹¹, Walter A. Sifuentes-Giraldo¹², Vanessa Smith¹³, Flavio Sztajnbok¹⁴, Tadey Avcin¹⁵, Maria Jose Santos¹⁶, Dana Nemkova¹⁷, Cristina Battagliotti¹⁸, Despina Eleftheriou¹⁹, Liora Harel²⁰, Mahesh Janarthanan²¹, Tilmann Kallinich²², Jordi Anton²³, Kirsten Minden², Susan Mary Nielsen²⁴, Kathryn S. Torok²⁵, Yosef Uziel²⁶ and Nicola Helmus¹, ¹Hamburg Center for Pediatric and Adolescent Rheumatology, Hamburg, Germany, ²Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ³Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Department of Pediatric Rheumatology, Istanbul, Turkey, ⁴Department of Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, ⁵University Childrens Hospital, Riga, Latvia, ⁶Pediatric Rheumatology Unit, Federal University of São Paulo, São Paulo, Brazil, ⁷Rheumatology, Scientific Center of Children's Health, Moscow, Russia, ⁸Service of Immunology & Rheumatology. Hospital de Pediatrìa Prof Dr.Juan.P. Garrahan, MD, Buenos Aires, Argentina, ⁹Pediatrics, University of Firenze, Firenze, Italy, ¹⁰Hospital Pediatrics, State Pediatric Medical University, Saint-Petersburg, Russia, ¹¹Chief Div Ped Rheum PTD, Hospital for Special Surgery, New York, NY, ¹²Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, ¹³Department of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, ¹⁴Pediatric Rheumatology Division, Adolescent Health Care Unit, Universida de do Estado do Rio de Janeiro., Rio de Janeiro, Brazil, ¹⁵University Children's Hospital, Ljubljana, Slovenia, ¹⁶Rheumatology, Department of Rheumatology, Hospital Garcia de Orta, Almada, Portugal, Almada, Portugal, ¹⁷Pediatric Rheumatology Unit, Department of Pediatrics and Adolescent Medicine, General University Hospital in Prague, Prague, Czech Republic, ¹⁸Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ¹⁹Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ²⁰Pediatric Rheumatology Unit, Schneider Children's Medical Center of Israel, Petach Tikvah, Israel, ²¹Pediatric Rheumatology, Chennai, India, ²²Charite, University Medicine Berlin, Berlin, Germany, ²³Unitat de Reumatologia Pediàtrica, Hospital Sant Joan de Déu, Barcelona, Spain, ²⁴Rigshospitalet, Copenhagen, Denmark, ²⁵Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ²⁶Meir Medical Center, Kfar Saba, Israel
Background/Purpose: Juvenile systemic sclerosis (jSSc) is an orphan autoimmune disease. Currently there is no data regarding use of medication in jSSc patients. Our project is…
Abstract Number: 1322 • 2014 ACR/ARHP Annual Meeting
Cardiopulmonary Involvement in Juvenile Systemic Sclerosis: Development of Recommendations for Screening and Investigation
Ivan Foeldvari¹, Clare Pain², Tamás Constantin³, Eileen Baildam⁴, Christian Beyer⁵, Michael Blakley⁶, Dana Nemkova⁷ and Clarissa A Pilkington⁸, ¹Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, ²Pediatric Rheumatology, University Children´s Hospital, Liverpool, United Kingdom, ³Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, ⁴Paediatric Rheumatology, Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, ⁵Pediatric Cardiology, Hamburg, Germany, ⁶Internal Medicine and Pediatrics, Indiana University School of Medicine and Riley Hospital for Children at IU Health, Indianapolis, IN, ⁷Pedaitric Rheumatology, Prague, Czech Republic, ⁸Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom
Background/Purpose There are currently no agreed recommendations on how to investigate children for cardiopulmonary involvement in Juvenile Systemic Sclerosis (JSSc). The aim of screening is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].